Detailed clinical evaluations, pedigree construction, haplotype analysis, and functional studies revealed a dominant‐acting RAD51C c.571 + 4A > G splicing variant residing on a shared HBOC‐associated haplotype that increases the risk for BC in addition to OC. This evidence concerns the gene RAD51C and breast cancer.